Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2772142 | 1.00 | POLB (0.31) | POLBCTDSP1TDP1 | |
| SCHEMBL1614393 | 1.00 | POLB (0.31) | POLBCTDSP1TDP1 | |
| SCHEMBL1613039 | 1.00 | POLB (0.31) | POLBCTDSP1TDP1 | |
| SCHEMBL1613043 | 1.00 | POLB (0.31) | POLBCTDSP1TDP1 | |
| SCHEMBL2772139 | 1.00 | POLB (0.31) | POLBCTDSP1TDP1 | |
| SCHEMBL2776496 | 0.80 | POLB (0.34) | POLBCTDSP1TDP1 | |
| SCHEMBL1613900 | 0.80 | POLB (0.34) | POLBCTDSP1TDP1 | |
| SCHEMBL2772006 | 0.76 | — | — | |
| SCHEMBL2771999 | 0.76 | — | — | |
| SCHEMBL2772433 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7812195-B2 | Cyclohexenyl butenones and fragrance compositions comprising them | GIVAUDAN SA (CH) | 2010-10-12 | — | — | US | claimed |
| EP-2094359-A1 | CYLOHEXENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM | Givaudan SA (CH) | 2009-09-02 | — | — | EP | claimed |
| WO-2008071026-A1 | CYLOHEXENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM | GIVAUDAN SA (CH) | 2008-06-19 | — | — | WO | claimed |
| EP-2167463-B1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | GIVAUDAN SA (CH) | 2013-06-12 | — | — | EP | disclosed |
| EP-2155844-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2012-11-21 | — | — | EP | disclosed |
| US-8278230-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-02 | — | — | US | disclosed |
| US-20110086793-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-04-14 | — | — | US | disclosed |
| US-7846887-B2 | Cysteine derivatives which counteract malodour | GIVAUDAN SA (CH) | 2010-12-07 | — | — | US | disclosed |
| US-7812195-B2 | Cyclohexenyl butenones and fragrance compositions comprising them | GIVAUDAN SA (CH) | 2010-10-12 | — | — | US | disclosed |
| US-20100179088-A1 | Cysteine Derivatives Which Counteract Malodour | GIVAUDAN SA (CH) | 2010-07-15 | — | — | US | disclosed |
| EP-2167463-A1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | Givaudan SA (CH) | 2010-03-31 | — | — | EP | disclosed |
| US-20100016197-A1 | Cyclohexenyl Butenones and Fragrance Compositions Comprising Them | GIVAUDAN SA (CH) | 2010-01-21 | — | — | US | disclosed |
| EP-2094359-A1 | CYLOHEXENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM | Givaudan SA (CH) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008154765-A1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | GIVAUDAN SA (CH) | 2008-12-24 | — | — | WO | disclosed |
| US-20080305977-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-11 | — | — | US | disclosed |
| WO-2008071026-A1 | CYLOHEXENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM | GIVAUDAN SA (CH) | 2008-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086793-A1 | PERFUME SYSTEMS | PAOX, PLIN5, PFKFB2 | POLB 425/4885CTDSP1 393/4885TDP1 2030/4885 |
| US-20100179088-A1 | Cysteine Derivatives Which Counteract Malodour | CBR3, CBR1, GSR | POLB 3839/4885CTDSP1 4649/4885TDP1 4744/4885 |
| US-20100016197-A1 | Cyclohexenyl Butenones and Fragrance Compositions Comprising Them | CBR3, C5, CYB5R3 | POLB 3083/4885CTDSP1 2111/4885TDP1 3820/4885 |
| US-20080305977-A1 | PERFUME SYSTEMS | PAOX, PLIN5, PFKFB2 | POLB 425/4885CTDSP1 393/4885TDP1 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.